Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Charlotte Wagner

Concepts (60)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
2
2023
134
0.940
 Why?
Etoposide
1
2024
148
0.870
 Why?
Cyclophosphamide
1
2024
234
0.860
 Why?
Oligopeptides
1
2024
258
0.780
 Why?
Cisplatin
1
2024
299
0.780
 Why?
Immunoconjugates
1
2023
104
0.780
 Why?
Dexamethasone
1
2024
350
0.760
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1560
0.540
 Why?
Anemia, Aplastic
2
2025
36
0.440
 Why?
Multiple Myeloma
2
2024
125
0.380
 Why?
Antilymphocyte Serum
1
2025
63
0.230
 Why?
Paraproteinemias
1
2024
5
0.230
 Why?
Idarubicin
1
2023
5
0.220
 Why?
B-Cell Maturation Antigen
1
2023
9
0.210
 Why?
Anaphylaxis
1
2025
98
0.210
 Why?
Peripheral Nervous System Diseases
1
2023
125
0.200
 Why?
Stem Cell Transplantation
1
2023
164
0.200
 Why?
Treatment Outcome
3
2024
10219
0.180
 Why?
Recurrence
1
2024
1011
0.180
 Why?
Immunotherapy, Adoptive
1
2023
300
0.170
 Why?
Drug Resistance, Neoplasm
1
2024
752
0.160
 Why?
Simeprevir
1
2018
9
0.150
 Why?
Heterocyclic Compounds, 3-Ring
1
2018
31
0.140
 Why?
Neoplasm Recurrence, Local
1
2023
958
0.140
 Why?
Chronic Disease
1
2023
1720
0.140
 Why?
Protease Inhibitors
1
2018
107
0.140
 Why?
Leukemia, Myeloid, Acute
1
2023
596
0.130
 Why?
HIV Integrase Inhibitors
1
2018
69
0.130
 Why?
Retrospective Studies
4
2025
14522
0.110
 Why?
Aged
3
2025
22061
0.090
 Why?
Humans
9
2025
129625
0.080
 Why?
Middle Aged
3
2025
31136
0.080
 Why?
Male
4
2025
63670
0.060
 Why?
Horses
1
2025
107
0.060
 Why?
Female
4
2025
68734
0.060
 Why?
Staurosporine
1
2023
20
0.050
 Why?
Infusions, Intravenous
1
2025
399
0.050
 Why?
Benzoates
1
2023
41
0.050
 Why?
Cytarabine
1
2023
57
0.050
 Why?
Multicenter Studies as Topic
1
2025
286
0.050
 Why?
Hydrazines
1
2023
34
0.050
 Why?
fms-Like Tyrosine Kinase 3
1
2023
47
0.050
 Why?
Remission Induction
1
2023
274
0.050
 Why?
Adult
4
2025
35599
0.040
 Why?
Immunosuppressive Agents
1
2023
858
0.040
 Why?
Oxazines
1
2018
27
0.040
 Why?
Area Under Curve
1
2018
304
0.030
 Why?
Incidence
1
2023
2641
0.030
 Why?
Pyridones
1
2018
158
0.030
 Why?
Hepacivirus
1
2018
239
0.030
 Why?
Piperazines
1
2018
340
0.030
 Why?
Hepatitis C
1
2018
243
0.030
 Why?
Drug Therapy, Combination
1
2018
1042
0.030
 Why?
Cohort Studies
1
2025
5426
0.030
 Why?
Mutation
1
2023
3717
0.020
 Why?
HIV-1
1
2018
838
0.020
 Why?
Young Adult
1
2025
12455
0.020
 Why?
Prospective Studies
1
2018
7135
0.020
 Why?
HIV Infections
1
2018
2730
0.010
 Why?
Animals
1
2025
35391
0.010
 Why?
Wagner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (60) concept(s)
_
Co-Authors Expand Description
See all (5) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)